Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidenceSyphilis treatment: old and newCommunity acquired bacterial pneumoniaCurrent treatment options to prevent perinatal transmission of herpes simplex virusAclidinium bromide for the treatment of chronic obstructive pulmonary diseaseProlonged-release formulation of melatonin (Circadin) for the treatment of insomniaTopical n -docosanol for management of recurrent herpes labialisBurns: an update on current pharmacotherapyPharmacotherapy of systemic sclerosisEvaluation of the clinical efficacy of asenapine in schizophreniaThe use of cephalosporins for gonorrhea: the impending problem of resistanceDalbavancin for the treatment of acute bacterial skin and skin structure infectionsA re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary diseaseAntituberculosis therapy for 2012 and beyondPharmacotherapy of postpartum depression: an updateAdvances in the treatment of invasive neonatal candidiasisProtein kinase inhibitors against malignant lymphomaClinical investigation of receptor and non-receptor tyrosine kinase inhibitors for the treatment of epithelial ovarian cancerThe role of aspirin in cardiovascular diseases--forgotten benefits?Aggrenox((R)) versus other pharmacotherapy in preventing recurrent strokePrevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectivenessAnti-inflammatory pharmacotherapy during pregnancyEssential thrombocythaemia in children: is a treatment needed?Clopidogrel for the secondary prevention of strokeAspirin and esomeprazole are superior to clopidogrel in preventing recurrent ulcer bleedingCOX-2 inhibitors vs. NSAIDs in gastrointestinal damage and preventionCurrent treatment practice for essential thrombocythaemia in adultsCLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarctionRibavirin--current status of a broad spectrum antiviral agentInnovative cancer drug targets: genomics, transcriptomics and clinomicsHomocysteine-lowering treatment: an overviewAntiplatelet therapy in secondary stroke preventionOpportunities for the treatment of inflammation in cardiovascular diseaseReview of risedronate in the treatment of osteoporosisA critical evaluation of the NICE guidelines for post-myocardial infarction prophylaxis. National Institute for Clinical ExcellenceResistance to antiplatelet drugs: current status and future researchClopidogrel: a CURE in acute coronary syndromes?Combining antiplatelet and thrombolytic therapies for strokeEptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIaMedications for the treatment of acute coronary syndromes
P1433
Q21032450-F789B24E-FF1F-4C94-80A1-CFD01DFF44A9Q22241378-F6DFBC9A-37C0-467D-8862-2627021E36C8Q22241379-5C0BB185-D0E6-4817-A24A-2CD517163B2BQ22306018-C76BBAE2-1422-426D-B2C1-1CDB40C791A0Q22306019-23517250-8137-4A0D-9219-22C15D707CB7Q22306021-59DA4A59-9261-4667-8DC9-3A8AD5BC5A00Q22306022-EBC2886A-3154-4098-9386-9F42D84E407FQ24618730-2909A021-321C-4923-96D1-110F371793F5Q24629481-3E615613-5544-41D6-816A-D4FF33840B65Q24630385-CBB0DE0B-EEA7-4F89-AD7E-1526E17261E1Q24656750-A91B11E5-826D-4ED4-8D25-A15C41CD382BQ26799598-65221FFF-52C7-41BA-8EEB-C2327360460FQ26801661-9FFAD620-8DB7-4A27-9BA6-7B57B4E6BD49Q26829101-23D38C2F-30D1-442F-9655-56FB1B389BCAQ27010062-A639CC29-EAED-4501-83B9-90F33F93BE6BQ27022585-DB718D1A-03C7-4329-8ECC-988EF83AA210Q27024212-376C7169-7FB1-4D5C-B623-6C33BA48839FQ27024235-846A19B3-0D62-4CE0-B9C4-002BA20BBF8CQ28166524-2FF1AC14-73A4-4C3D-A190-A1F1A950BBA2Q28166526-57A24F44-B2E2-4DD9-8753-B3AD218457F6Q28167713-CCE73C7E-0DC2-49A8-8781-EBD9E2470C3AQ28167716-FD229151-5DBA-415F-8DE4-24A1D90C37A2Q28168696-B240080D-01F2-4164-94DF-E3CE20D0DB0BQ28176560-21CB3D68-E088-4BCB-B9F5-65854B1447CAQ28177240-41478089-FA9D-41FB-8DF9-D63093A30548Q28182917-32001EC2-8B19-40E8-AC08-09339AA1754BQ28182932-E88E8326-9160-4A90-9B47-A9C912668703Q28186321-0A3476A5-A018-4834-92C8-45AA88EFAE33Q28190105-6B6ACD7A-A1DA-4C3E-B8C2-204BA61AF1BDQ28190114-E971E145-2B4C-4E09-83A4-3B7DECF0B842Q28190121-F10CBB60-1853-4D7C-98BD-46035B5F8519Q28192290-FEBEADB1-E469-49A3-8225-B33D85CEC784Q28192292-6BDF13F2-84C1-47D8-98CA-231A4813EB66Q28192294-BCFC09DF-BB7A-4306-A93D-66DA01762B2EQ28192295-3C39C444-430D-4F73-AF4C-0D08A78B57A0Q28192298-1FA7B50C-C9C7-4385-AB45-452F55043E55Q28192438-B264022B-F5B1-4BC9-A211-4837B8EDC155Q28192702-86B045FF-863C-459D-83E2-DBAC06E5645DQ28193526-EEC8AAEA-1680-4365-9DA6-F040230A774EQ28193674-64683E24-FBCF-4422-BFAD-6DD97E648010
P1433
description
begutachtete wissenschaftliche Zeitschrift
@de
peer-reviewed scientific journal
@en
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Informa
@nl
рецензований науковий журнал
@uk
वैज्ञानिक पत्रिका
@hi
name
Expert Opinion on Pharmacotherapy
@ast
Expert Opinion on Pharmacotherapy
@da
Expert Opinion on Pharmacotherapy
@de
Expert Opinion on Pharmacotherapy
@en
Expert Opinion on Pharmacotherapy
@es
Expert Opinion on Pharmacotherapy
@fi
Expert Opinion on Pharmacotherapy
@fr
Expert Opinion on Pharmacotherapy
@it
Expert Opinion on Pharmacotherapy
@nb
Expert Opinion on Pharmacotherapy
@nl
type
label
Expert Opinion on Pharmacotherapy
@ast
Expert Opinion on Pharmacotherapy
@da
Expert Opinion on Pharmacotherapy
@de
Expert Opinion on Pharmacotherapy
@en
Expert Opinion on Pharmacotherapy
@es
Expert Opinion on Pharmacotherapy
@fi
Expert Opinion on Pharmacotherapy
@fr
Expert Opinion on Pharmacotherapy
@it
Expert Opinion on Pharmacotherapy
@nb
Expert Opinion on Pharmacotherapy
@nl
prefLabel
Expert Opinion on Pharmacotherapy
@ast
Expert Opinion on Pharmacotherapy
@da
Expert Opinion on Pharmacotherapy
@de
Expert Opinion on Pharmacotherapy
@en
Expert Opinion on Pharmacotherapy
@es
Expert Opinion on Pharmacotherapy
@fi
Expert Opinion on Pharmacotherapy
@fr
Expert Opinion on Pharmacotherapy
@it
Expert Opinion on Pharmacotherapy
@nb
Expert Opinion on Pharmacotherapy
@nl
P243
P3181
P101
P1055
P1058
P1156
P1159
P123
P1277
P1476
Expert Opinion on Pharmacotherapy
@en
P236
P243
P3181
P407
P571
1999-01-01T00:00:00Z